Kumar Abhishek, Caceres Jose D, Vaithilingam Siddharthan, Sandhu Gurshan, Meena Nikhil K
Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Nevada, Las Vegas, NV 89102, USA.
Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Diagnostics (Basel). 2021 Aug 15;11(8):1479. doi: 10.3390/diagnostics11081479.
Despite many advancements in recent years for the sampling of peripheral pulmonary lesions, the diagnostic yield remains low. Initial excitement about the current electromagnetic navigation platforms has subsided as the real-world data shows a significantly lower diagnostic sensitivity of ~70%. "CT-to-body divergence" has been identified as a major limitation of this modality. In-tandem use of the ultrathin bronchoscope and radial endobronchial ultrasound probe has yielded only comparable results, attributable to the limited peripheral reach, device maneuverability, stability, and distractors like atelectasis. As such, experts have identified three key steps in peripheral nodule sampling-navigation (to the lesion), confirmation (of the correct location), and acquisition (tissue sampling by tools). Robotic bronchoscopy (RB) is a novel innovation that aspires to improve upon these aspects and consequently, achieve a better diagnostic yield. Through this publication, we aim to review the technical aspects, safety, feasibility, and early efficacy data for this new diagnostic modality.
尽管近年来在周围型肺部病变采样方面取得了许多进展,但诊断率仍然很低。随着实际数据显示当前电磁导航平台的诊断敏感性显著降低至约70%,最初对其的兴奋之情已经消退。“CT与身体的偏差”已被确定为这种方式的主要限制。超薄支气管镜和径向支气管内超声探头的串联使用仅产生了类似的结果,这归因于外周可达性有限、设备可操作性、稳定性以及诸如肺不张等干扰因素。因此,专家们确定了周围结节采样的三个关键步骤——导航(至病变部位)、确认(正确位置)和采集(用工具进行组织采样)。机器人支气管镜检查(RB)是一项旨在改进这些方面从而提高诊断率的新创新技术。通过本出版物,我们旨在回顾这种新诊断方式的技术方面、安全性、可行性和早期疗效数据。